medigraphic.com

2001, Number S1

<< Back Next >>

Arch Cardiol Mex 2001; 71 (S1)

Myocardial revascularization in patients with acute myocardial infarction complicated by cardiogenic shock

Gil MR

Language: Spanish
References: 13
Page: 54-57
PDF size: 38.74 Kb.


ABSTRACT

In the last 20 years, the acute myocardial infarction 30 day mortality rate has been reduced significantly, following pharmacological and mechanical reperfusion therapies. Nevertheless, cardiogenic shock complicating acute myocardial infarction remains the leading cause of death because of the extensive ventricular function damage non. Randomized studies were overoptimistic reporting markedly lower mortality rates among patients who had undergone revascularization for shock. Further randomised studies showed that the angiographic improvement is not always followed by a significant mortality reduction. However, angiographic study and revascularisation is the treatment of choice. In addition to an early reperfussion, new pharmacological and/or genetic ways to improve the ventricular function have to be found.


REFERENCES

  1. TIEFENBRUNN AJ, CHANDRA NC, FRENCH WJ, GORE JM, ROGERS WJ: Clinical experience with primary percutaneous transluminal coronary angioplast, compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998; 31: 1240-5.

  2. HOCHMAN JS, BOLAND J, SLEEPER LA, PORWAY M, BRINKER J, COL J, JACOBS A, SLATER J, MILLER D, WASSERMAN H, MENEGUS MA, TALLEY D, MCKINLAY S, SANBOM T, LeJemtel and the SHOCK Registry Investigators: Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International registry. Circulation 1995; 91: 873-81.

  3. HARNARAYAN C, BENNETT MA, PENTECOST BC, BREWER DB: Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J 1970; 32: 728-32.

  4. HOLMES DR JR, BATES ER, KLEIMAN NS, SADOWSKI Z, HORGAN JH, MORRIS DC, CALIFF RM, BERGER PB, TOPOL EJ: Contemporary reperfusion therapy for cardiogenic shock: The GUSTO 1 trial experience. The GUSTO 1 Investigators. J Am Coll Cardiol 1995; 26: 668-74.

  5. BERGER PB, HOLMES DR, STEBBINS AL, BATES ER, CALIFF RM, TOPOL EJ, for the GUSTO 1 investigators: Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO 1) trial. An observational study. Circulation 1997; 96: 122-7.

  6. ANTONIUCCI D, VALENTI R, SANTORO GM. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998; 31: 294-300.

  7. PÉREZ CASTELLANO N, GARCÍA E, SERRANO JA, ALIZAGA J, SORIANO J, ABEYTUA M, BOTAS J, RUBIO R, LÓPEZ DE SA E, LÓPEZ-SENDÓN JL, DELCAN JL: Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 1999; 83: 989-93.

  8. URBAN P, STAUFFER JC, BLEED D, KHATCHATRIAN N, AMANN W, BERTEL O, VAN DEN BRAND M, DANCHIN N, KAUFMANN U, MEIER B, MACHECOURT J, Pfsterer M for the (S)MASH investigators: A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. Eur Heart J 1999; 20: 1030-1038.

  9. HOCHMAN JS, SLEEPER LA, WEBB JG, SANBORN TA, WHITE HD, TALLEY JD, BULLER CE, JACOBS AK, SLATER JN, COL J, MCKINLAY M, LEJEMTEL TH: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. New Eng J Med 1999; 341: 625-34.

  10. HOCHMAN JS, BULLER CE, SLEEPER LA, BOLAND J, DZAVIK V, SANBORN TA, GODFEY E, WHITE HD, LIM J, LEJEMTEL T, for the SHOCK investigators: Cardiogenic Shock complicating acute myocardial infarction-Etiologies, management and outcome: A report from the SHOCK trial registry. J Am Coll Cardiol 2000; 36-1063-70

  11. RYAN TJ. Early revascularization in cardiogenic shock. A positive view of a negative trial (editorial). New Eng1 J Med 1999; 687-8.

  12. ZEYMER U, VOGT A, NIEDERER U, TEBBE U, ENGEL HJ, HEINRICH W, MERX W, PFAFFEROTT C, GOTTWIK M, NEUHAUS KL: Primary PTCA with and without stent implantation complicated by cardiogenic shock: results of the ALKK primary- PTCA registry. Eur Heart J 2000; 21: 132.

  13. MORENO R, GARCÍA E, SORIANO J, ABEYTUA M, ELÍZAGA J, BOTAS J, LÓPEZ SÁ E, RUBIO R, LÓPEZ-SENDÓN JL, DELCÁN JL: Early coronary angioplasty for actue myocardial infarction complicated by cardiogenic shock: have novel therapies led to better results? Eur Heart J 2000; 21: 14.




2020     |     www.medigraphic.com